🔎 Trials Near Me

Gara Jalqabaatti › Baayyee Ulfaataa › Tennessee › Knoxville

Qorannoo klinikaalii Baayyee Ulfaataa Knoxville, TN keessatti

Qorannoo 7 Baayyee Ulfaataa f Knoxville fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Namoota walitti qabaa jiraSadarkaa 3
  • New Phase Research and Development, Knoxville
  • Accellacare US Inc., d/b/a Accellacare of Knoxville, Knoxville
Umuriin 18 hanga 99 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07684235

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Namoota walitti qabaa jiraSadarkaa 3
  • Accellacare of Knoxville, Knoxville
  • Cardiovascular Research of Knoxville North Knoxville Medical Center, Powell · Miili 8 fagaatti
Umuriin 45 hanga 99 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07037433

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Namoota walitti qabaa jiraSadarkaa 2
  • New Phase Research & Development /ID# 282131, Knoxville
  • Summit Medical Group- Halls Family Physicians /ID# 282435, Knoxville
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT07752979

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

Namoota walitti qabaa jiraSadarkaa 3
  • New Phase Research and Development, Knoxville
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07794579

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Namoota walitti qabaa jiraSadarkaa 3
  • Research Site, Knoxville
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07784270

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

Namoota walitti qabaa jiraSadarkaa 3
  • ACCOMPLISH-1 Research Site, Knoxville
Umuriin 18 hanga 79 · Saalaa hunda · Haaromfame 10-Hag-2026 · NCT07654361

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MBX 4291 in Adult Participants With Obesity

Namoota walitti qabaa jiraSadarkaa 1
  • MBX Biosciences Investigational Site, Knoxville
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 09-Wax-2026 · NCT07142707

Qorannoo Baayyee Ulfaataa magaalota biroo keessatti

Qorannoo biroo Knoxville keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.